Reconocimiento de alteraciones retinales en diagnóstico de enfermedad de Fabry: un reporte de caso
Ciencia y Tecnología para la Salud Visual y Ocular

Abstract

Introduction: Fabry´s disease is a genetic disorder that courses with systemic and ocular manifestations, showing changes in the cornea, conjunctiva, and retina. Objective: To describe the retinal alterations identified in a patient diagnosed with Fabry´s disease in Rionegro, Antioquia in 2024, based on a case report. Case description: The ocular manifestations of a patient diagnosed with Fabry´s disease in Rionegro, Antioquia, were described and confirmed through specialized assessments and interdisciplinary management A 25-year-old female patient referred to decreased visual acuity in the right eye. An ophthalmologist referral was made, identifying vascular retinopathy in the affected eye. Genetic counseling is conducted to determine the final course of action and follow-up for the patient. Conclusions: Fabry disease is a rare pathology, with systemic and ocular involvement. Some of the systemic manifestations may be like other conditions of this type, and when these characteristics are associated with ocular damage, the diagnosis could be easier. The most frequent findings in the eye are in the cornea, conjunctiva, and retina, although some patients do not show alterations in this structure. The case reported in this document showed retinal vasculitis, but no changes were detected in the anterior segment of the eye. Interdisciplinary management was performed, and enzyme replacement therapy was indicated.

PDF (Spanish)

References

Orphanet: Enfermedad de Fabry [Internet]. Disponible en: https://www.orpha.net/es/disease/detail/324

Vernon HJ. ENFERMEDAD DE FABRY - OMIM- #301500 [Internet]. 2022. Disponible en: https://omim.org/entry/301500

Barros LR, Jiménez SJ, Roncallo A, López F, Conde JC, Martínez T, et al. Colombian consensus of experts on evidence -based recommendations for diagnosis, treatment and follow-up of fabry’s disease with renal involvement. Revista Colombiana de Nefrología [Internet]. 24 de febrero de 2022; 9(1): e591-e591. Disponible en: https://revistanefrologia.org/index.php/rcn/article/view/591

Fundación Nacional de la Enfermedad de Fabry. ¿Cuántas personas padecen la enfermedad de Fabry? [Internet]. 2008. Disponible en: https://www.fabrydisease.org/about-fabry-disease/how-many-people-have-fabry-disease

Bokhari SRA, Zulfiqar H, Hariz A. Fabry Disease. StatPearls [Internet]. 4 de julio de 2023; Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK435996/

Rodríguez-González-Herrero ME, Marín-Sánchez JM, Gimeno JR, Molero-Izquierdo C, De-Casas-Fernández A, Rodríguez-González-Herrero B, et al. Manifestaciones oftalmológicas en la Enfermedad de Fabry: A propósito de 4 casos con actividad deficiente de a-Galactosidasa A. Arch Soc Esp Oftalmol [Internet]. diciembre de 2008; 83(12): 713-7. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365-66912008001200006&lng=es&nrm=iso&tlng=es

Instituto Nacional de Salud, Ministerio de Salud. Comportamiento de la notificación al Sivigila de las enfermedades - huérfanas - Raras, Colombia, 2016 hasta SE 04 de 2021. En: Boletín Epidemiológico Semanal - BES. 2021.

Iester M, Sodi A, Occella C, Vittone P. Ocular findings in Fabry’s disease. Contrib Nephrol [Internet]. 2001; 136(136): 260-2. Disponible en: https://pubmed.ncbi.nlm.nih.gov/11688391/

Orssaud C, Dufier JL, Germain DP. Ocular manifestations in Fabry disease: a survey of 32 hemizygous male patients. Ophthalmic Genet [Internet]. septiembre de 2003; 24(3):129-39. Disponible en: https://pubmed.ncbi.nlm.nih.gov/12868031/

Nguyen TT, Gin T, Nicholls K, Low M, Galanos J, Crawford A. Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre. Clin Exp Ophthalmol [Internet]. abril de 2005; 33(2):164-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/15807825/

Pérez-Velarde J, Duarte-Iribe N, Álvarez-Villarreal A. Evolución oftalmológica en paciente con enfermedad de Fabry posterior a Terapia de Reemplazo Enzimático: Presentación de caso. Revista Médica de la Universidad Autónoma de Sinaloa REVMEDUAS [Internet]. 3 de julio de 2023; 13(1): 59-65. Disponible en: http://dx.doi.org/10.28960/revmeduas.2007-8013.v13.n1.008

Wiest MRJ, Toro MD, Nowak A, Baur J, Fasler K, Hamann T, et al. Globotrioasylsphingosine Levels and Optical Coherence Tomography Angiography in Fabry Disease Patients. J Clin Med [Internet]. 1 de marzo de 2021; 10(5): 1-12. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33807900/

Lin Z, Pan X, Mao K, Jiao Q, Chen Y, Zhong Y, et al. Quantitative evaluation of retinal and choroidal changes in Fabry disease using optical coherence tomography angiography. Lasers Med Sci [Internet]. 1 de febrero de 2022; 37(1): 269-77. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33409749/

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Metrics

Metrics Loading ...

Downloads

Download data is not yet available.

Keywords

Fabry disease
retinal vasculitis
Glycosphingolipids

How to Cite

Cardozo Roa, J. T., Guerra Carpintero, L. A., & Narváez Rumié, O. M. (2025). Reconocimiento de alteraciones retinales en diagnóstico de enfermedad de Fabry: un reporte de caso. Ciencia Y Tecnología Para La Salud Visual Y Ocular, 22(2). https://doi.org/10.19052/svo.22.iss2.5371